|
SMFM Special Statement: Cognitive bias and medical error in obstetrics- Challenges and opportunities
|
SMFM Statement
|
SMFM, F Atallah, RF Hamm, CM Davidson, CA Combs, Patient Safety and Quality Committee |
2022 |
|
SFP Interim clinical recommendations: self-managed abortion
|
SMFM Endorsed Partner Publication
|
SFP |
2022 |
|
ISPD Updated Position Statement on the use of genome-wide sequencing for prenatal diagnosis
|
SMFM Endorsed Partner Publication
|
ISPD |
2022 |
|
ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests
|
|
ACOG |
2022 |
|
SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial
|
SMFM Statement
|
SMFM, Publications Committee |
2022 |
|
SMFM Special Statement: Race in maternal-fetal medicine research- Dispelling myths and taking an ...
|
SMFM Statement
|
SMFM |
2022 |
|
SMFM Special Statement: A critique of postpartum readmission rate as a quality metric
|
SMFM Statement
|
SMFM |
2022 |
|
SMFM Special Statement: Commitment to excellence in obstetrical care, research, and education for...
|
SMFM Statement
|
SMFM |
2022 |
|
SMFM Consult Series #60: Management of pregnancies resulting from in vitro fertilization
|
Consult Series
|
SMFM |
2022 |
|
SMFM Special Statement: A quality metric for evaluating timely treatment of severe hypertension
|
Maternal Medical Complications
SMFM Special Report
|
SMFM Patient Safety and Quality Committee; CA Combs, JR Allbert, I Taylor, C Allen |
2022 |
|
ACOG-SMFM Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related ...
|
Joint Publication
|
ACOG and SMFM |
2021 |
|
SMFM Special Statement: COVID-19 research in pregnancy: progress and potential
|
SMFM Statement
|
SMFM |
2021 |
|
SMFM Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine
|
SMFM Statement
|
SMFM |
2021 |
|
SMFM Special Statement: Surgical safety checklists for cesarean delivery
|
SMFM Statement
|
SMFM |
2021 |
|
SMFM Fetal Anomalies Consult Series #4: Genitourinary anomalies
|
Consult Series
|
SMFM |
2021 |
|
SMFM Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preter...
|
Consult Series
|
SMFM |
2021 |
|
SMFM Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneupl...
|
Consult Series
|
SMFM |
2021 |
|
ACOG-SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of Gestation
|
Joint Publication
|
ACOG and SMFM |
2021 |
|
Executive summary: Workshop on Preeclampsia, January 25–26, 2021, cosponsored by the Society for ...
|
SMFM Special Report
|
SMFM |
2021 |
|
SMFM Consult Series #56, Hepatitis C in pregnancy—updated guidelines
|
Consult Series
|
SMFM |
2021 |